JPRN-UMIN000027482已完成未知
Complement activation and ADAMTS13 suppression may contribute to the characteristic pathological features in Upshaw-Schulman Syndrome - Complement activation and ADAMTS13 suppression in USS
ara medical university0 个研究点目标入组 5 人开始时间: 2017年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
Chronic glomerular sclerotic changes in the majority of USS cases (4 of 5), with minor glomerular pathology in the remaining case. In two of these four severe cases, more than half of the glomerular segmental sclerosis area was localized in the perihilar region. The average number of ADAMTS13-positive cells per glomerulus was significantly lower in USS cases than controls (p < 0.05). C4d staining was significantly more prevalent in the glomerular capillary walls of USS cases than controls (p < 0.05).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Transplanted kidney
研究者
相似试验
已完成
不适用
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney DiseaseAtypical Hemolytic Uraemic SyndromeNCT00930423University Hospital, Ghent25
招募中
不适用
Nephrotic Syndrome Study NetworkMinimal Change Disease (MCD)Glomerulosclerosis, Focal SegmentalMembranous NephropathyNCT01209000University of Michigan1,200
已完成
1 期
DS-5565 Clinical Pharmacology Study in Japanese Subjects with varying degrees of renal functioJPRN-jRCT2080222129DAIICHISANKYO Co.,Ltd.30
Enrolling By Invitation
不适用
The Effect of Education Based on Orem's Self-Care Deficit Theory and Tele-Monitoring on Rational Drug Use in Haemodialysis PatientsHaemodialysisNCT06689228Akdeniz University70
已完成
4 期
Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial EffectsFocal Segmental GlomerulosclerosisNCT02585804University Health Network, Toronto10
